Lilly produces medicines to meet patients' healthcare needs. We believe that it is critical for patients to have access to our products, which save and improve lives. Therefore, Lilly is committed to participating in the political process as a responsible corporate citizen to help inform the debates regarding health care and pharmaceutical innovation globally.
Lilly considers a variety of factors and stakeholder input to determine which issues are most relevant for engagement. These factors include patient needs, conversations and interviews with stakeholders, investor queries and feedback, business strategy, public policy dialogue and legislative debate, and employee interests.